Avenue Therapeutics (ATXI) Misses Q1 EPS by 640c

Avenue Therapeutics (NASDAQ: ATXI) reported Q1 EPS of ($15.40), $6.40 worse than the analyst estimate of ($9.00).

For earnings history and earnings-related data on Avenue Therapeutics (ATXI) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Unity Bancorp CEO to retire in 2027, president to take over
• Paychex (PAYX) Tops Q1 EPS by 2c